Akagera-Medicines

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Akagera-Medicines" (27 articles)
Company registration in Rwanda is complete in 24 hours. Craish BAHIZI

What makes “a Good Company" in Rwanda?

Tuesday, March 10, 2026
President Paul Kagame delivers his remarks during the diplomatic dinner on Friday, March 6. Photo by Dan Gatsinzi

Rwanda’s impossible choice

Sunday, March 08, 2026
Prof. Dr. Richard Gurgel from the University of Utah led the team that performed the sugery at King Faisal Hospital.

One refugee child’s impact on hearing care in Rwanda

Friday, February 20, 2026
(L–R) A moderator leads a panel discussion with Bill Gates, the American philanthropist and co-chair of the Gates Foundation, Rwanda’s Minister of ICT and Innovation Paula Musoni, and Global Fund Executive Director Peter Sands at the World Economic Forum (WEF) annual meeting in Davos on Wednesday, January 21. Courtesy

Rwanda’s next accomplishment: Turning Gates–OpenAI’s Horizon1000 into people‑centered AI

Tuesday, January 27, 2026
According to the World Health Organization’s annual report on TB, in 2024, estimated numbers of new cases continue to decline in sub-Saharan Africa, while efforts to detect new cases continue to gain traction.

The future can be bright in the fight against TB

Wednesday, January 14, 2026
The New Times

Africa “experts”: Moral certainty and local ignorance

Saturday, December 06, 2025
The New Times

The next generation and Rwanda’s biotech sector

Friday, September 12, 2025
Minister of Health Dr Sabin Nsanzimana speaks at the launch of “health intelligence centre on Thursday, April 2. Photos by Kellya Keza
Health

Rwanda to fully digitise health records by December

Tuesday, April 22, 2025
Akagera Medicines said it has completed early-stages of its preclinical trials of AKG-100, a new antibiotic drug in the oxazolidinone class, designed to treat pulmonary TB.
Health

Akagera Medicines’ TB drug shows ‘promising’ results in preclinical trials

Tuesday, April 01, 2025
A medic takes care of a patient at King Faisal Hospital. Scientists are increasingly alarmed by the growing threat of zoonotic diseases—infections that jump from animals to humans. File
Health

Covid, Mpox, bird flu, MVD: Why viruses jump from animals to humans

Wednesday, December 18, 2024
European Investment Bank (EIB Global) has announced a new financing arrangement towards Akagera Medicines Africa. INTERNET PHOTO
Science

European Investment Bank backs Akagera’s vaccine development in Rwanda

Monday, October 14, 2024
Rugemanshuro said the proposed Fund is expected to be launched this year.. File
Economy

RSSB to launch Rwf30bn equity investment facility for SMEs

Wednesday, May 29, 2024